Аннотация:
The information about the founders of studies of the bladder function in our country, the features of the nervous and humoral regulation of the lower urinary tract activity, the cholinergic and adrenergic effects of mediators are presented in the article in the form of a clinical lecture. The pathogenetic features of detrusor dysfunction in overactive bladder and the principles of choosing drug therapy are described. Special attention is paid to the comparative characteristics of modern M-anticholinergics.
Рубрики Mesh:
Холинергические антагонисты - терапевтическое применение
Человек
Мочевой пузырь сверхактивный
Мочевой пузырь сверхактивный - лекарственная терапия
Журнальная статья
Borisov V.V.
FGAOU VO I.M. Sechenov First Moscow State Medical University, Moscow, Russia.
Overactive bladder pathogenetic features and choice of drug therapy
Текст визуальный электронный
Urologiia (Moscow, Russia : 1999)
№ 2 С. 120-127
2021
M-anticholinergics
overactive bladder
urge incontinence
urgency
urination
Статья
Cholinergic Antagonists therapeutic use D27.505.519.625.120.200 D27.505.696.577.120.200
Холинергические антагонисты терапевтическое применение D27.505.519.625.120.200 D27.505.696.577.120.200
Humans B01.050.150.900.649.313.988.400.112.400.400
Человек B01.050.150.900.649.313.988.400.112.400.400
Urinary Bladder, Overactive C12.050.351.968.829.813 C12.200.777.829.866 C12.950.829.813 C23.888.942.343.780
Urinary Bladder, Overactive drug therapy C12.050.351.968.829.813 C12.200.777.829.866 C12.950.829.813 C23.888.942.343.780
Мочевой пузырь сверхактивный C12.050.351.968.829.813 C12.200.777.829.866 C12.950.829.813 C23.888.942.343.780
Мочевой пузырь сверхактивный лекарственная терапия C12.050.351.968.829.813 C12.200.777.829.866 C12.950.829.813 C23.888.942.343.780
Journal Article V02.600
Журнальная статья V02.600
The information about the founders of studies of the bladder function in our country, the features of the nervous and humoral regulation of the lower urinary tract activity, the cholinergic and adrenergic effects of mediators are presented in the article in the form of a clinical lecture. The pathogenetic features of detrusor dysfunction in overactive bladder and the principles of choosing drug therapy are described. Special attention is paid to the comparative characteristics of modern M-anticholinergics.